Saxenda litigation — Baltimore City | DrugsMonitor.com

Educational overview of Saxenda litigation in Baltimore City, Maryland. Metro cities, court context, and filing considerations—not legal advice.

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes., Baltimore City, Maryland

Baltimore City

County-level educational overview for Saxenda litigation in Baltimore City, Maryland.

• Baltimore, MD